secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001420720-25-000014
Event type: other_material
Sentiment:  positive
Materiality: 0.35
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio voluntarily delists from NYSE American, lists on Nasdaq Capital Market effective March 4, 2025
--------------------------------------------------------------------------------

- Board authorized voluntary withdrawal from NYSE American and listing on Nasdaq Capital Market on Feb 19, 2025.
- Last NYSE American trade expected at market close March 3, 2025; Nasdaq trading starts market open March 4, 2025.
- Ticker symbol 'IBIO' remains unchanged on both exchanges.
- CEO Martin Brenner says move expected to improve stock visibility, trading liquidity, and institutional investor exposure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000142072025000014/0001420720-25-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000142072025000014/ibio-20250219x8k.htm
  HTML page:      https://secwatch.observer/filing/0001420720-25-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer